Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

NHS National Framework for Tafamidis

NHS England

This public procurement record has 7 releases in its history.

AwardUpdate

13 Oct 2026 at 12:07

UK6 - Contract Award Notice
Award

02 Oct 2026 at 09:26

UK6 - Contract Award Notice
TenderUpdate

31 Jul 2026 at 09:50

UK4 - Tender Notice
Tender

31 Jul 2026 at 09:46

UK4 - Tender Notice
PlanningUpdate

14 Jul 2026 at 17:34

UK1 - Pipeline Notice
Planning

08 May 2026 at 07:07

UK2 - Preliminary Market Engagement Notice
Planning

23 Apr 2026 at 08:28

UK1 - Pipeline Notice
Summary of the contracting process

NHS England has awarded a national framework for the supply of tafamidis, a pharmaceutical product, for use across England. The requirement is for tafamidis medicines, including wild-type tafamidis, with supply to NHS purchasing points. The framework is intended to support NHS medicine procurement and access across participating healthcare buyers. Its scope is organised as a single lot, covering the product requirement rather than separate regional or product lots. This is a medicines supply opportunity, not a request for clinical services or construction work. Suppliers with relevant tafamidis products and the ability to serve NHS purchasing points across the country are the closest fit.

The procurement is complete and was run as an open procedure using a framework agreement with competition reopened for subsequent call-offs. Seven valid bids were recorded. The award is pending and was made on 29 September 2026 to Cipla and Pfizer Ltd, for a combined award value of £62,393,000 excluding VAT (£74,871,600 including VAT). The framework period runs from 1 April 2027 to 31 May 2028, with extension options at NHS England’s discretion for up to a further 24 months, to a latest end date of 31 May 2030. The original estimated procurement value was £65,281,000 excluding VAT. The lot states that price is not the only award criterion and records a 100% weighting; the published criterion description does not explain the apparent weighting in more detail.

This award confirms a substantial NHS requirement for tafamidis, with national purchasing reach and a framework route that reopens competition for call-offs. Cipla and Pfizer were selected from seven valid bidders, showing that the field included both established pharmaceutical suppliers and smaller businesses. A credible competitor when this requirement returns would need a relevant tafamidis product, dependable supply capacity across NHS purchasing points, and the ability to participate in a national framework and compete in later call-offs. The procurement documents included a quality assurance process and quality control technical sheet, so suppliers should be ready to evidence product quality and meet NHS medicines procurement controls. Price mattered, but the stated basis indicates that non-price factors also formed part of the evaluation.

How relevant is this notice?

Notice Information

Notice Title

NHS National Framework for Tafamidis

Notice Description

Project title: NHS National Framework for Tafamidis Offer reference number: CM/TNS/26/5750 Period of framework: 01 April 2027 to 31 May 2028 (14 months) with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

Lot Information

Lot 1

Renewal: Option or options to extend (at the discretion of the Authority) up to a maximum of 24 months

Planning Information

NHS England is seeking to engage with current or potential new suppliers that are planning to launch any of the molecule(s) that will be covered by this procurement. Interested suppliers will be invited to a virtual preliminary market engagement meeting. The purpose of these sessions is to update suppliers regarding timelines and to discuss product details, product launches during the proposed framework period, tender structure, and KPI's. Please contact katie.noonan@nhs.net or marie.graney1@nhs.net to register your interest in tendering for this framework.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-068921
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/096493-2026
Current Stage
Award
All Stages
Planning, Tender, Award

Procurement Classification

Notice Type
UK6 - Contract Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
SME
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£65,281,000 £10M-£100M
Lots Value
£65,281,000 £10M-£100M
Awards Value
£62,393,000 £10M-£100M
Contracts Value
Not specified

Notice Dates

Publication Date
13 Oct 20261 weeks ago
Submission Deadline
31 Aug 2026Expired
Future Notice Date
31 Jul 2026Expired
Award Date
29 Sep 20263 weeks ago
Contract Period
1 Apr 2027 - 31 May 2028 1-2 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Pending
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LONDON
Postcode
SE1 8UG
Postcode Area
South East London
Country
England
Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI4 Inner London - East
Small Region (ITL 3)
TLI45 Lambeth
Delivery Location
TLC North East (England), TLD North West (England), TLF East Midlands (England), TLG West Midlands (England), TLH East (England), TLJ South East (England), TLK South West (England)
Local Authority
Lambeth
Electoral Ward
Waterloo & South Bank
Westminster Constituency
Vauxhall and Camberwell Green

Supplier Information

Number of Suppliers
2
Supplier Names

Cipla

Pfizer Ltd

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...